Uninterrupted anticoagulation during pacemaker or defibrillator surgeryBMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f3087 (Published 15 May 2013) Cite this as: BMJ 2013;346:f3087
The management of anticoagulation during surgery for a pacemaker or implantable cardioverter defibrillator involves balancing the risk of bleeding against the risk of thromboembolism. Guidelines currently recommend switching from warfarin to more flexible heparins around the time of the procedure, …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial